http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-003.html

At 11:44 AM 10/8/2008, you wrote:
>I'm trying to locate the link on the NIH site in order to include it in on
>our website and NOT-OD-09-003 is not producing any results when I search for
>it.  Does anyone have the direct link to the notice they could share with
>me?
>Thank you!
>
>-----Original Message-----
>From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of
>Aull, Robert Matthew
>Sent: Wednesday, October 08, 2008 10:42 AM
>To: xxxxxx@hrinet.org
>Subject: [RESADM-L] New NIH Policy on Resubmission (Amended) Applications
>
>NIH has revised its renewal policy from three strikes to "two strikes and
>you're out."
>
>Currently funded projects will be grandfathered to allow three attempts for
>continued funding but they won't accept any -A2 applications after January
>7, 2011.
>
>1st try: R01AA012345-06
>2nd try: R01AA012345-06A1
>3rd try: R01AA012345-06A2 (NLT 7 Jan 11)
>
>Robert Aull
>Indiana University
>
>
>New NIH Policy on Resubmission (Amended) Applications
>----------------------------------------------------------------------------
>
>Notice Number: NOT-OD-09-003
>
>Key Dates
>Release Date:  October 8, 2008
>
>Issued by
>National Institutes of Health (NIH), (http://www.nih.gov)
>
>Purpose
>
>NIH announces a change in the existing policy on resubmission (amended)
>applications (see http://grants.nih.gov/grants/policy/amendedapps.htm).
>Beginning with original new applications (i.e., never submitted) and
>competing renewal applications submitted for the January 25, 2009 due dates
>and beyond, the NIH will accept only a single amendment to the original
>application.  Failure to receive funding after two submissions (i.e., the
>original and the single amendment) will mean that the applicant should
>substantially re-design the project rather than simply change the
>application in response to previous reviews.  It is expected that this
>policy will lead to funding high quality applications earlier, with fewer
>resubmissions.
>
>Background
>
>Following the release of the Peer Review Report that was drafted with
>extensive consultation with the external community, Dr. Zerhouni, NIH
>Director, established a Peer Review Oversight Committee (PROC) to finalize
>the recommendations and begin immediate implementation of those
>recommendations.  Of particular concern was the marked reduction in the
>number of awards made in response to original applications.  An increasing
>number of projects were funded only after one or more resubmissions.   In
>periods of constricted funding, a greater number of projects require
>resubmission, and review committees are more likely to show greater
>preference for amended applications.  These trends have increased the time
>from original submission to award and the number of submissions per
>investigator. As a result, there has been greater burden placed on
>applicants and reviewers as well as a delay in funding for meritorious
>science.
>
>To change this trend and increase the likelihood that meritorious original
>applications will be funded, the NIH will decrease the number of amendments
>allowed.  Accordingly, the NIH will begin to phase out second amendment
>applications starting with the January 25, 2009 due date. This policy will
>increase the numbers of high quality original and first amendments that can
>be funded earlier.
>
>NIH Policy on Resubmission (Amended) Applications
>
>Beginning with applications intended for the January 25, 2009 due date, all
>original new applications (i.e., never submitted) and competing renewal
>applications will be permitted only a single amendment (A1).  For this and
>subsequent cohorts of original new and competing renewal applications, any
>second amendment (A2) will be administratively withdrawn and not accepted
>for review.   Applicants who fail to receive funding after two submissions
>may resubmit but only if the application is fundamentally revised to qualify
>as new.  A new application is expected to be substantially different in
>content and scope with more significant differences than are normally
>encountered in an amended application.  Note that there is no time limit for
>the submission of the original and subsequent A1.
>
>Original new and competing renewal applications that were submitted prior to
>January 25, 2009 will be permitted two amendments (A1 and A2).  For these
>"grandfathered" applications, NIH expects that any A2 will be submitted no
>later than January 7, 2011, and NIH will not accept A2 applications after
>that date.
>
>This policy applies to all applications, including applications submitted
>under the NIH Small Business Innovation Research (SBIR) and Small Business
>Technology Transfer (STTR) programs, Career Development Awards, Individual
>Fellowships, Institutional Training Grants, Resource Grants, Program
>Projects, and Centers.  Currently no amendments are permitted for
>applications received in response to a Request for Applications (RFA) unless
>it is specified in the Funding Opportunity Announcement, in which case only
>one amendment will be permitted.  ations (RFA) unless it is specified in the
>Funding Opportunity Announcement, in which case only one amendment will be
>permitted.
>
>Inquiries
>
>Applicants are strongly encouraged to discuss their questions with their NIH
>IC contact.  For additional information or questions, please contact:
>
>Division of Receipt and Referral
>Center for Scientific Review
>6701 Rockledge Drive MSC 7720
>Bethesda, MD  20892-7720
>Voice:  (301) 435-0715
>Fax:  (301) 480-1987
>
>Or send an email to xxxxxx@mail.nih.gov.
>
>Clinicalmail is a service provided by the Association of American Medical
>Colleges
>
>
>======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
>======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================